Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 3;1(1):e000023.
doi: 10.1136/bmjpo-2017-000023. eCollection 2017.

Plasma citrate concentration: a possible biomarker for glaucoma in children

Affiliations

Plasma citrate concentration: a possible biomarker for glaucoma in children

Marta Michalczuk et al. BMJ Paediatr Open. .

Abstract

Objectives: The main aim of the present study was to examine a possible role of plasma and urine citrate levels as glaucoma indicators in school-aged children with glaucoma diagnosis.

Patients: 34 school-aged children with a glaucoma diagnosis (mean age 15.69±1.86 years) were qualified for the study group and 34 patients with no ophthalmological ailments were qualified for the control group (mean age 16.1±1.98 years). Plasma and urine citrate levels in the study and the control group (Kruskal-Wallis test) were compared.

Results: Plasma citrate levels in the study (16.33±4.51 mg/L) and the control group (19.11±3.66 mg/L) were different; the statistical significance (p=0.0036). Plasma citrate concentrations were significantly lower in the study group in comparison with the control group. There were no statistically important differences between the study group (291.12±259.13 mg/24 hours; 275.82±217.57 mg/g) and the control group (434.88±357.66 mg/24 hours; 329.81±383.27 mg/g) including urine citrate level (p=0.052) and urine citrate to creatine ratio (p=0.4667).

Conclusion: Plasma citrate concentration might be considered as glaucoma biomarker in paediatric population.

Keywords: Ophthalmology; screening.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Whiskers diagrams highlight plasma citrate level differences between test and control group.

References

    1. AAO. The American Academy of Ophthalmology. Primary Open-Angle Glaucoma PPP 2015:P 49–-77.
    1. Aponte EP, Diehl N, Mohney BG. Incidence and clinical characteristics of childhood glaucoma: a population-based study. Arch Ophthalmol 2010;128:478–82. doi:10.1001/archophthalmol.2010.41 - DOI - PMC - PubMed
    1. Kokotas H, Kroupis C, Chiras D, et al. . Biomarkers in primary open angle glaucoma. Clin Chem Lab Med 2012;50:2107–19. doi:10.1515/cclm-2012-0048 - DOI - PubMed
    1. Golubnitschaja O, Yeghiazaryan K, Flammer J. Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible? Epma J 2010;1:237–44. doi:10.1007/s13167-010-0031-4 - DOI - PMC - PubMed
    1. Weinstein BI, Iyer RB, Binstock JM, et al. . Decreased 3 alpha-hydroxysteroid dehydrogenase activity in peripheral blood lymphocytes from patients with primary open angle glaucoma. Exp Eye Res 1996;62:39–46. doi:10.1006/exer.1996.0005 - DOI - PubMed

LinkOut - more resources